LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus.

Journal of Feline Medicine and Surgery
Rodrigo S HortaArchivaldo Reche Júnior

Abstract

The aim of this study was to establish the safety and efficacy of a novel multidrug lomustine-based chemotherapeutic protocol for cats with high-grade multicentric or mediastinal lymphoma, in an area endemic for feline leukemia virus (FeLV). This prospective study included owned cats, diagnosed (cytologically) with multicentric or mediastinal lymphoma and treated with the LOPH (lomustine, vincristine [Oncovin; Antibióticos do Brasil], prednisolone and hydroxydaunorubicin [doxorubicin]) protocol. A complete blood count was performed before every chemotherapy session and any significant abnormalities recorded as possible related toxicities. Median survival time (MST) and disease-free interval were estimated by Kaplan-Meier curves. Twenty-one cats were included in this study. Nineteen (90.5%) tested positive for FeLV and were therefore considered to have persistent viremia. Complete response was reported in 81% (n = 17/21), while three had partial remission and one had no response. Seven cats finished the induction protocol within 20-31 weeks (23.1 ± 4.5; median 20) and all seven received a maintenance protocol. The MST (lymphoma-related survival) for the 21 cats was 214 days. The MST was 214 days for cats with mediastinal lymphom...Continue Reading

References

May 1, 1989·Veterinary Immunology and Immunopathology·M Reinacher
Apr 10, 1995·International Journal of Cancer. Journal International Du Cancer·A TerryJ C Neil
Nov 1, 1996·Journal of Veterinary Internal Medicine·A S MooreD A L'Heureux
Apr 13, 2001·Journal of Veterinary Internal Medicine·O KristalA S Moore
Nov 22, 2001·Journal of Feline Medicine and Surgery·C G Couto
Feb 15, 2005·Journal of the American Veterinary Medical Association·Shinobu KomoriMasahiro Tagawa
Feb 22, 2008·Journal of Veterinary Internal Medicine·A G HaddenP Morrissey
Mar 4, 2008·Journal of Veterinary Internal Medicine·D SimonI Nolte
Nov 1, 2008·Journal of Feline Medicine and Surgery·Karen T OberthalerKarin U Sorenmo
Apr 2, 2009·FEBS Letters·Lora W FormanSajal K Ghosh
Jul 7, 2009·Journal of Feline Medicine and Surgery·Amy E LingardVanessa R Barrs
Mar 17, 2010·Journal of the American Veterinary Medical Association·Karin U SorenmoKenneth J Drobatz
Dec 15, 2010·Pharmacogenetics and Genomics·Christina J RamirezKatrina L Mealey
May 12, 2012·Journal of Feline Medicine and Surgery·Autumn L DutelleMona P Rosenberg
Jul 10, 2012·Journal of Feline Medicine and Surgery·Margaret L MusserJohn D Chretin
Sep 1, 2016·Journal of Feline Medicine and Surgery·Birgitt WolfesbergerAndrea Fuchs-Baumgartinger
May 17, 2017·Veterinary and Comparative Oncology·P M BrownV Langova
May 24, 2017·Journal of the American Animal Hospital Association·Jessica Renee FinlayCourtney North
Jun 13, 2018·Veterinary and Comparative Oncology·J L BissonS A Argyle

❮ Previous
Next ❯

Citations

Nov 13, 2020·Journal of Feline Medicine and Surgery·Katherine SmallwoodLaura Blackwood

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
biopsy

Software Mentioned

Graph Pad Prism

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.